Bill Summary for S 20 (2013-2014)

Printer-friendly: Click to view

Summary date: 

Mar 4 2013

Bill Information:

View NCGA Bill Details2013-2014 Session
Senate Bill 20 (Public) Filed Wednesday, January 30, 2013
A BILL ENTITLED AN ACT TO PROVIDE LIMITED IMMUNITY FROM PROSECUTION FOR (1) CERTAIN DRUG-RELATED OFFENSES COMMITTED BY AN INDIVIDUAL WHO SEEKS MEDICAL ASSISTANCE FOR A PERSON EXPERIENCING A DRUG-RELATED OVERDOSE AND (2) CERTAIN DRUG -RELATED OFFENSES COMMITTED BY AN INDIVIDUAL EXPERIENCING A DRUG-RELATED OVERDOSE AND IN NEED OF MEDICAL ASSISTANCE; TO PROVIDE IMMUNITY FROM CIVIL OR CRIMINAL LIABILITY FOR (1) PRACTITIONERS WHO PRESCRIBE AN OPIOID ANTAGONIST TO CERTAIN THIRD PARTIES AND (2) CERTAIN INDIVIDUALS WHO ADMINISTER AN OPIOID ANTAGONIST TO A PERSON EXPERIENCING A DRUG-RELATED OVERDOSE; AND TO PROVIDE LIMITED IMMUNITY FROM PROSECUTION FOR CERTAIN ALCOHOL-RELATED OFFENSES COMMITTED BY PERSONS UNDER THE AGE OF 21 WHO SEEK MEDICAL ASSISTANCE FOR ANOTHER PERSON.
Intro. by Bingham, Allran.

View: All Summaries for BillTracking:

Bill summary

Senate committee substitute makes the following changes to the 1st edition.

Amends GS 90-106.2 as follows.

Adds language that permits a practitioner, that is prescribing, dispensing, or distributing an opioid antagonist, to require the receipt of a written communication that provides a factual basis for concluding that the person seeking the opiod antagnonist is at risk of an opiate-related overdose or that a person who is not at risk of experiencing the overdose but is seeking the opioid antagonist is a family member, friend, or other person and is in the position to help a person at risk of experiencing the opiate-related overdose.

Adds language defining evidence of the use of reasonable care in administering an opioid antagnonist as the receipt of basic instruction and information on how to administer the opioid antagonist.

Amends the act's effective date, changing it to apply new GS 90-96.2 to persons needing or seeking medical assistance on or after December 1, 2013, and GS 90-106.2 as becoming effective December 1, 2013 and applying to persons prescribing, dispensing, distributing, or administering an opioid antagonist on or after that date.